Project Grant K01MH134764
- This Project Grant award of $173,197 from the Fogarty International Center (CFDA 93.989 - International Research and Research Training) supports a collaborative research project between Brown University, Beijing Normal University, and Emory University. The project aims to develop and test a mobile health (mHealth) intervention focused on stigma reduction and gender affirmation to engage Chinese transgender women in HIV prevention, mental health promotion, and access to community resources. The...
- Federal Grant Award Summary The Fogarty International Center (FIC) awarded Impact Research and Development Organisation (IRDO) a $234,292 Project Grant under the International Research and Research Training program (CFDA 93.989) to develop and pilot test a multilevel, community-based intervention targeting pre-exposure prophylaxis (PrEP) stigma reduction among adolescent girls and young women (AGYW) ages 15-24 in western Kenya. The project, which commenced on September 13, 2025 and concludes...
- Federal Grant Award Summary The John E. Fogarty International Center (FIC) awarded Partnership For Research And Action For Health a $192,292 Project Grant (CFDA 93.989 – International Research and Research Training) effective April 1, 2026, through March 31, 2029, to reduce HIV stigma and enhance prevention efforts among men who have sex with men (MSM) in the Georgian Republic. The grant supports the development and pilot testing of a digital health intervention comprised of culturally adapted...
- Federal Grant Award Summary The Los Angeles LGBT Center received a $150,000 Project Grant from the HIV/AIDS Bureau under the HIV-Related Training and Technical Assistance program (CFDA 93.145) effective September 1, 2025, through August 31, 2026. The award funds the establishment of a Transition in Care Registered Nurse (RN) position to enhance early engagement and retention for low-income and underserved people living with HIV (PLWH). The RN position will facilitate comprehensive assessments,...
- This Project Grant award from the Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program will fund the development and evaluation of an online contraception decision aid, titled "ContraceptionForAll", for transgender and gender-nonconforming (TGNC) individuals assigned female at birth (AFAB). The $391,458 award will be used to: (1) engage TGNC AFAB individuals in participatory design to enhance an existing...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $281,480 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Maryland, Baltimore, effective September 12, 2025, with a completion date of August 31, 2030. The award supports secondary analysis research examining the role of sex hormones and gender-affirming hormone therapy in anal human papillomavirus (HPV) persistence and...
- Federal Grant Award Summary This K99/R00 Research Career Development Award of $135,540 was obligated to Brigham & Women's Hospital Inc. on September 3, 2025, under the National Institute of Allergy and Infectious Diseases' Allergy and Infectious Diseases Research program (CFDA 93.855). The award supports a two-phase career development initiative focused on advancing HIV/AIDS prevention and treatment through innovation in long-acting injectable (LAI) delivery systems. During the K99 phase,...
- This Project Grant award of $193,754, funded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), aims to develop an implementation strategy for pre-exposure prophylaxis (PrEP) based on academic detailing to improve prescribing and use among adolescents and young adults (AYA) in pediatric primary care settings. The primary objectives are to: 1) explore barriers and facilitators to PrEP discussions, prescribing, and persistence among...
- The Johns Hopkins University received a $431,804 Project Grant award from the Fogarty International Center (FIC) under the International Research and Research Training program (CFDA 93.989), effective September 15, 2025, through June 30, 2028. This research initiative will develop and evaluate a multi-level stigma mitigation intervention package designed to improve antiretroviral therapy (ART) adherence and achieve viral suppression among women living with HIV (WLHIV) across the lifespan in...
- PHARMA-GIRL Project Grant Summary The University of California, San Francisco received a $408,643 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) for the period February 1, 2026 through January 31, 2028. The award funds a mixed-methods implementation science study titled "PHARMA-GIRL: Empowering Adolescent Girls and Young Women with Choice and Prevention in...
INTERSECTIONAL DISCRIMINATION AND LINKAGE TO HIV PREVENTION AND CARE IN TRANSGENDER WOMEN IN ECUADOR - 7. PROJECT SUMMARY-ABSTRACT LATIN AMERICA DID NOT ACHIEVE ANY REDUCTIONS IN NEW HIV CASES IN THE LAST DECADE. IN ECUADOR, TRANSGENDER WOMEN-THOSE WHO IDENTIFY AS WOMEN OR ON THE TRANSFEMININE SPECTRUM AND WHO WERE ASSIGNED A MALE SEX AT BIRTH-WHO HAVE SEX WITH CISGENDER MEN ARE A KEY POPULATION IN THE HIV EPIDEMIC. HIV PREVALENCE IN ECUADOR IS BETWEEN 20.7%-34.8% AMONG TRANSGENDER WOMEN-THE HIGHEST IN LATIN AMERICA. STUDIES ARE URGENTLY NEEDED TO GUIDE HIV PREVENTION AND CARE EFFORTS TO CURB HIV INFECTION RATES. PEOPLE WITH MULTIPLE MARGINALIZED IDENTITIES, SUCH AS TRANSGENDER WOMEN OF AFRICAN DESCENT LIVING IN POVERTY, ARE AT HIGHER RISK OF EXPOSURE TO INTERSECTIONAL DISCRIMINATION THAN THE GENERAL U.S. POPULATION AND HAVE HIGH RATES OF HIV. YET THE EXTENT TO WHICH ECUADORIAN TRANSGENDER WOMEN ARE BURDENED BY INTERSECTIONAL DISCRIMINATION AND ITS EFFECT ON THE LINKAGE TO HIV PREVENTION AND CARE OUTCOMES REMAINS UNKNOWN. THIS K01 AWARD WILL PROVIDE THE CANDIDATE WITH TRAINING IN INTERSECTIONAL QUALITATIVE, QUANTITATIVE, INTERVENTION DEVELOPMENT, AND GRANT WRITING TO ADDRESS THE CHALLENGE OF INTERSECTIONAL DISCRIMINATION AND HIV BURDEN IN TRANSGENDER WOMEN IN ECUADOR. THE PROPOSED RESEARCH WILL ASSESS THE MECHANISMS THROUGH WHICH INTERSECTIONAL DISCRIMINATION EXERTS ITS IMPACT ON LINKAGE TO HIV PREVENTION AND CARE FOR TRANSGENDER WOMEN IN ECUADOR WHILE EXTENDING AND DEEPENING CANDIDATE'S RESEARCH SKILLS. IN RESEARCH AIM 1, THE CANDIDATE WILL ASSESS EXPERIENCES OF INTERSECTIONAL DISCRIMINATION (E.G., HIV STIGMA, RACISM, CLASSISM) IN RELATION TO HIV PREVENTION AND CARE THROUGH IN-DEPTH QUALITATIVE INTERVIEWS WITH TRANSGENDER WOMEN (TRAINING AIM 1: APPLICATION OF INTERSECTIONALITY TO QUALITATIVE METHODS). IN RESEARCH AIM 2, THE CANDIDATE WILL CONDUCT A SURVEY TO CHARACTERIZE AND LONGITUDINALLY TEST THE PATHWAYS THAT LINK INTERSECTIONAL DISCRIMINATION WITH HIV PREVENTION AND CARE LINKAGE OUTCOMES OVER A 6-MONTH PERIOD (TRAINING AIM 2: EPIDEMIOLOGICAL METHODS AND LONGITUDINAL QUANTITATIVE RESEARCH DESIGN). IN RESEARCH AIM 3, THE CANDIDATE WILL IMPLEMENT THE FIRST SIX PHASES OF THE SYSTEMATIC ADAPT-ITT MODEL TO ADAPT AN HIV INTERVENTION FOR TRANSGENDER WOMEN (TRAINING AIM 3: SKILLS FOR INTERVENTION DEVELOPMENT). FINDINGS FROM THIS STUDY AND TRAINING WILL POSITION THE CANDIDATE TO DEVELOP AN R01 PROPOSAL TO IMPLEMENT REMAINING STEPS OF THE ADAPT-ITT MODEL AND CONDUCT A RANDOMIZED CONTROLLED TRIAL OF THE INTERVENTION (TRAINING AIM 4: GRANT WRITING). AS AN ECUADORIAN NON-BINARY QUEER U.S. IMMIGRANT RESEARCHER, THE CANDIDATE HAS THE CULTURAL AND RESEARCH BACKGROUND TO LEVERAGE THIS PROPOSED K01 TO TRANSITION TO CAREER INDEPENDENCE AND ADDRESS KEY KNOWLEDGE AND INTERVENTION GAPS FOR HIV PREVENTION AND CARE IN ECUADOR.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 2/5/26 | ||
| Not listed | $0 | 12/10/25 | ||
| Not listed | $0 | 12/10/25 | ||
| Not listed | $0 | 3/24/25 | ||
| Not listed | $0 | 3/24/25 |